ClinicalTrials.gg
Status unknownNCT03830047Updated Aug 6, 2019

Effect of Laser in Treatment of Vulval Warts

An interventional study of nd yag laser in Vulval Wart, sponsored by Aljazeera Hospital. Status unknown at 3 sites in Egypt. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-06.

Sponsored by Aljazeera Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Vulval warts is a magor problem that affects women .

Read the detailed description

The causative organism for vulval warts is human papilloma virus There are many treatment modalities that can trat these warts

02

Conditions studied

  • Vulval Wart
03

In context

Lead sponsor

Aljazeera Hospital is the lead sponsor of 64 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women who have vulval warts
  • Age between 18- 40 years

Exclusion criteria

Exclusion Criteria:

  • warts that were previously treated by surgery or cryotherapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    nd yag laser

    Applying nd yag laser to vulva

    Device: nd yag laser

  • Sham comparator
    Co2 laser

    Applying CO2 laser to vulva

    Device: nd yag laser

Interventions

  • Devicend yag laser

    nd yag laser will be applied on the vulval warts

    Also known as: laser beam

06

What researchers measure

Primary outcomes

  1. The number of women who will be completely cured by laser beam

    how laser will cure the warts

    Time frame: within 2 months

07

Study locations

2 of 3 sites recruiting
  • Algazeerah and Kasralainy hospital
    Giza, Egypt
    Not yet recruiting
    • Mahmoud Alalfy, master · Contactmahmoudalalfy@ymail.com · +201002611058
    • Ahmed Elgazzar, M.D · Contact+201014005959
    • Mahmoud Alalfy, master · Principal investigator
  • Algazeerah
    Giza, Egypt
    Recruiting
    • Mahmoud Alalfy, master · Contactmahmoudalalfy@ymail.com · +201002611058
    • Ahmed Elgazzar, M.D · Contact+201014005959
    • Mahmoud Alalfy, master · Principal investigator
  • Aljazeera( Al Gazeera) hospital
    Giza, Egypt
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03830047
Lead sponsor
Aljazeera Hospital
Collaborators
National Research Centre, Egypt
Responsible party
Sponsor
First posted
Feb 5, 2019
Start date
Feb 7, 2019
Primary completion
Oct 15, 2019 (estimated)
Completion
Nov 20, 2019 (estimated)
Last update
Aug 6, 2019

Study contacts

Mahmoud Alalfy, PhD
Contact
mahmoudalalfy@ymail.com
01002611058
Mahmoud Alalfy, PhD
principal investigator · Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion